1-3 of 3
Authors: Henrik Maagensen
Journal Article
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes Get access
European Journal of Endocrinology, Volume 187, Issue 4, Oct 2022, Pages 507–518, https://doi.org/10.1530/EJE-22-0291
Published: 16 September 2022
Journal Article
The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes Get access
European Journal of Endocrinology, Volume 186, Issue 2, Feb 2022, Pages 207–221, https://doi.org/10.1530/EJE-21-0865
Published: 06 January 2022
Journal Article
Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 5, May 2018, Pages 2042–2049, https://doi.org/10.1210/jc.2018-00176
Published: 01 March 2018
